Ingestible “bacteria on a chip” could help diagnose disease

Ingestible “bacteria on a chip” could help diagnose disease

  • May 28, 2018
Table of Contents

Ingestible “bacteria on a chip” could help diagnose disease

This “bacteria-on-a-chip” approach combines sensors made from living cells with ultra-low-power electronics that convert the bacterial response into a wireless signal that can be read by a smartphone. In the new study, appearing in the May 24 online edition of Science, the researchers created sensors that respond to heme, a component of blood, and showed that they work in pigs. They also designed sensors that can respond to a molecule that is a marker of inflammation.

In the past decade, synthetic biologists have made great strides in engineering bacteria to respond to stimuli such as environmental pollutants or markers of disease. These bacteria can be designed to produce outputs such as light when they detect the target stimulus, but specialized lab equipment is usually required to measure this response. To make these bacteria more useful for real-world applications, the MIT team decided to combine them with an electronic chip that could translate the bacterial response into a wireless signal.

For their initial demonstration, the researchers focused on bleeding in the GI tract. They engineered a probiotic strain of E. coli to express a genetic circuit that causes the bacteria to emit light when they encounter heme. The researchers tested the ingestible sensor in pigs and showed that it could correctly determine whether any blood was present in the stomach.

They anticipate that this type of sensor could be either deployed for one-time use or designed to remain the digestive tract for several days or weeks, sending continuous signals.

Source: mit.edu

Share :
comments powered by Disqus

Related Posts

Leading UK scientist reveals likely cause of childhood leukaemia

Leading UK scientist reveals likely cause of childhood leukaemia

Professor Mel Greaves from The Institute of Cancer Research, London, assessed the most comprehensive body of evidence ever collected on acute lymphoblastic leukaemia (ALL) – the most common type of childhood cancer. His research concludes that the disease is caused through a two-step process of genetic mutation and exposure to infection that means it may be preventable with treatments to stimulate or ‘prime’ the immune system in infancy. The first step involves a genetic mutation that occurs before birth in the foetus and predisposes children to leukaemia – but only 1 per cent of children born with this genetic change go on to develop the disease.

Read More
How an AI Startup Could Defeat Now Unbeatable Bugs

How an AI Startup Could Defeat Now Unbeatable Bugs

The need for new medications is higher than ever, but so is the cost and time to bring them to market. Developing a new drug can cost billions and take as long as 14 years, according to the U.S. Food and Drug Administration. Yet with all that effort, only 8 percent of drugs make it to market, the FDA said.

Read More